<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Raeder SB</submitter><pubmed_abstract>Antimicrobial resistance is an increasing threat to global health and challenges the way we treat infections. Peptides containing the PCNA interacting motif APIM (APIM-peptides) were recently shown to bind to the bacterial PCNA homolog, the beta (β)-clamp, and to have both antibacterial and anti-mutagenic activities. In this study we explore the antibacterial effects of these peptides on &lt;i>Staphylococcus epidermidis&lt;/i>, a bacterial species commonly found in prosthetic joint infections (PJI). Drug-resistant bacterial isolates from PJIs often lead to difficult-to-treat chronic infections. We show that APIM-peptides have a rapid bactericidal effect which when used at sublethal levels also increase the efficacy of gentamicin. In addition, APIM-peptides reduce development and eliminate alread</pubmed_abstract><journal>Frontiers in microbiology</journal><pagination>631557</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8009970</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Novel Peptides Targeting the β-Clamp Rapidly Kill Planktonic and Biofilm &lt;i>Staphylococcus epidermidis&lt;/i> Both &lt;i>in vitro&lt;/i> and &lt;i>in vivo&lt;/i>.</pubmed_title><pmcid>PMC8009970</pmcid><pubmed_authors>Bergh K</pubmed_authors><pubmed_authors>Witso E</pubmed_authors><pubmed_authors>Nepal A</pubmed_authors><pubmed_authors>Otterlei M</pubmed_authors><pubmed_authors>Sandbakken ET</pubmed_authors><pubmed_authors>Loseth K</pubmed_authors><pubmed_authors>Raeder SB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Novel Peptides Targeting the β-Clamp Rapidly Kill Planktonic and Biofilm &lt;i>Staphylococcus epidermidis&lt;/i> Both &lt;i>in vitro&lt;/i> and &lt;i>in vivo&lt;/i>.</name><description>Antimicrobial resistance is an increasing threat to global health and challenges the way we treat infections. Peptides containing the PCNA interacting motif APIM (APIM-peptides) were recently shown to bind to the bacterial PCNA homolog, the beta (β)-clamp, and to have both antibacterial and anti-mutagenic activities. In this study we explore the antibacterial effects of these peptides on &lt;i>Staphylococcus epidermidis&lt;/i>, a bacterial species commonly found in prosthetic joint infections (PJI). Drug-resistant bacterial isolates from PJIs often lead to difficult-to-treat chronic infections. We show that APIM-peptides have a rapid bactericidal effect which when used at sublethal levels also increase the efficacy of gentamicin. In addition, APIM-peptides reduce development and eliminate alread</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-04-04T18:37:47.616Z</modification><creation>2022-02-09T12:46:49.952Z</creation></dates><accession>S-EPMC8009970</accession><cross_references><pubmed>33815313</pubmed><doi>10.3389/fmicb.2021.631557</doi></cross_references></HashMap>